Intellectual Property
Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.
Sign up for a 7-day FREE trial today!
Latest News in Intellectual Property
-
September 22, 2017
Amgen Gets $70M In Biosimilar Patent Suit Against Hospira
A Delaware federal jury awarded Amgen Inc. $70 million in damages late Friday after finding that Hospira Inc. infringed a patent for the anemia treatment Epogen, rejecting Hospira's argument that it was protected by a safe harbor meant for companies seeking federal approval for biosimilar products.
-
September 22, 2017
Fed. Circ. Ruling To Force More Patent Cases Out Of EDTX
A Federal Circuit decision Thursday setting guidelines where patent suits can be filed — and rejecting venue rules set by an Eastern District of Texas judge — provides need much-needed clarity in a contentious area of the law and should result in many cases leaving the Texas court, attorneys say.
-
September 22, 2017
PTAB Invalidation Not Enough To Stay Arista ITC Import Ban
The Federal Circuit on Friday denied Arista Networks’ request to stay a U.S. International Trade Commission ban on its products that infringe on Cisco Systems’ networking equipment patents that the Patent Trial and Appeal Board later invalidated, but said Arista’s redesigned products could enter the country.
-
September 22, 2017
PTAB Says Fairchild Merger Doesn't Bar IPR Challenge
A Patent Trial and Appeal Board panel on Friday allowed ON Semiconductor Corp. to challenge Power Integrations Inc.’s electronic power regulation patent despite having undergone a merger with Fairchild Semiconductor International Inc., finding the patent invalid as obvious.
-
September 22, 2017
Mass. Case May Lead Policyholders To Limit Litigation Costs
Massachusetts' highest court recently agreed to review a ruling that shoe maker Vibram's insurance companies can't recoup the sums they paid to defend the company in a trademark dispute, and attorneys say a ruling that the insurers do have a right to reimbursement could lead policyholders to try to limit their litigation costs.
Areas of Coverage
- LITIGATION
- Infringement suits over patents, copyrights, and trademarks
- Patent Trial and Appeal Board disputes
- Abbreviated New Drug Application (ANDA) litigation
- Section 301 cases
- Trade secrets disputes
- Licensing and royalty fights
- Right-of-publicity suits
- Antitrust disputes involving IP issues
- AGENCIES
- U.S. Patent and Trademark Office
- U.S. Copyright Office
- U.S. International Trade Commission
- World Intellectual Property Organization
- POLICY & REGULATION
- Patent reform legislation and related bills in Congress
- Efforts to streamline international intellectual property law
- ENFORCEMENT
- Piracy and counterfeiting actions
- International trade disputes involving IP issues
- PROFILES
- Personnel moves
- Profiles of IP practices
Readership
- Intellectual property lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the life sciences, technology, and other IP-focused industries
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals